SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: heidi medline who wrote (575)4/1/1998 7:20:00 AM
From: majormember  Respond to of 4140
 
heidi:

Phase III is going very well. The FDA is giving
SNRS unprecedented leeway in the clinical trails:
biz.yahoo.com

I also suggest you visit the website:
sunrise-tech.com
ask for an investor package and video. You will find
much info. Lastly if you have been reading this thread
over the last 3-4 months, go back and re-read. You will
find all the answers to your questions.

Best wishes,
Skane



To: heidi medline who wrote (575)4/1/1998 7:53:00 AM
From: EmuGreg  Read Replies (1) | Respond to of 4140
 
Paul, an earlier version of LTK used separately triggered laser beams instead of 8 SIMULTANEOUS beams. The approach using non-simultaneous beams did cause distortions in the eye. However, that problem was solved with the introduction of the simultaneous protocol.

In the end, being able to treat astigmatism will probably be the mother-lode for SNRS.

Regards.
Greg


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News